AR029098A1 - Anticuerpos capaces de detectar selectivamente isoformas de prion prpsc - Google Patents

Anticuerpos capaces de detectar selectivamente isoformas de prion prpsc

Info

Publication number
AR029098A1
AR029098A1 ARP010102453A ARP010102453A AR029098A1 AR 029098 A1 AR029098 A1 AR 029098A1 AR P010102453 A ARP010102453 A AR P010102453A AR P010102453 A ARP010102453 A AR P010102453A AR 029098 A1 AR029098 A1 AR 029098A1
Authority
AR
Argentina
Prior art keywords
antibodies
selectly
prpsc prion
vcjd
bse
Prior art date
Application number
ARP010102453A
Other languages
English (en)
Spanish (es)
Original Assignee
Blood Transfusion Ct Of Sloven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8168816&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR029098(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Blood Transfusion Ct Of Sloven filed Critical Blood Transfusion Ct Of Sloven
Publication of AR029098A1 publication Critical patent/AR029098A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ARP010102453A 2000-05-23 2001-05-23 Anticuerpos capaces de detectar selectivamente isoformas de prion prpsc AR029098A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00111108A EP1158003B2 (en) 2000-05-23 2000-05-23 Antibodies capable to selectively detect prion PrP Sc isoforms

Publications (1)

Publication Number Publication Date
AR029098A1 true AR029098A1 (es) 2003-06-04

Family

ID=8168816

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102453A AR029098A1 (es) 2000-05-23 2001-05-23 Anticuerpos capaces de detectar selectivamente isoformas de prion prpsc

Country Status (14)

Country Link
EP (1) EP1158003B2 (https=)
JP (1) JP5042430B2 (https=)
KR (1) KR100829447B1 (https=)
CN (1) CN1250572C (https=)
AR (1) AR029098A1 (https=)
AT (1) ATE312848T1 (https=)
AU (2) AU2001284355B2 (https=)
CA (1) CA2407905C (https=)
DE (1) DE60024787T3 (https=)
DK (1) DK1158003T4 (https=)
ES (1) ES2253156T5 (https=)
HU (1) HU229454B1 (https=)
PL (1) PL208292B1 (https=)
WO (1) WO2001090191A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059386A2 (en) * 2002-01-18 2003-07-24 Cytos Biotechnology Ag Prion protein carrier-conjugates
EP1596199A1 (en) * 2004-05-14 2005-11-16 Prionics AG Method for the detection of disease-related prion
JP4246777B1 (ja) * 2007-11-20 2009-04-02 森永乳業株式会社 異常型プリオン蛋白質結合剤および異常型プリオン蛋白質の検出方法
EP2135880A1 (en) * 2008-06-17 2009-12-23 Heinrich-Heine-Universität Düsseldorf Anti-prion protein antibody fragment
AU2009301580B2 (en) 2008-10-06 2015-11-26 The University Of British Columbia Methods and systems for predicting misfolded protein epitopes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ246059A (en) * 1991-12-03 1995-08-28 Proteus Molecular Design Synthetic polypeptides with at least one antigenic site of a prion protein, methods of their use and manufacture, antibodies thereto, compositions and kits
DE852011T1 (de) * 1995-09-14 2001-10-11 Scripps Res Inst La Jolla Für natives prp-sc spezifische antikörper
EP0861900A1 (en) † 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
DE19741607A1 (de) * 1997-09-20 1999-03-25 Prionics Ag Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen

Also Published As

Publication number Publication date
ES2253156T5 (es) 2013-04-30
DE60024787T3 (de) 2013-06-06
CN1441811A (zh) 2003-09-10
AU8435501A (en) 2001-12-03
AU2001284355B2 (en) 2005-11-10
PL208292B1 (pl) 2011-04-29
EP1158003B2 (en) 2012-12-26
EP1158003A1 (en) 2001-11-28
HUP0302413A2 (hu) 2003-10-28
HU229454B1 (en) 2013-12-30
WO2001090191A3 (en) 2002-06-20
ATE312848T1 (de) 2005-12-15
EP1158003B1 (en) 2005-12-14
PL360139A1 (en) 2004-09-06
WO2001090191A2 (en) 2001-11-29
ES2253156T3 (es) 2006-06-01
JP2003534000A (ja) 2003-11-18
DK1158003T4 (da) 2013-04-08
KR20030014234A (ko) 2003-02-15
KR100829447B1 (ko) 2008-05-15
CA2407905A1 (en) 2001-11-29
DK1158003T3 (da) 2006-05-01
JP5042430B2 (ja) 2012-10-03
DE60024787T2 (de) 2006-09-07
CN1250572C (zh) 2006-04-12
CA2407905C (en) 2012-08-14
DE60024787D1 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
Mangé et al. Alpha‐and beta‐cleavages of the amino‐terminus of the cellular prion protein
ES2375958T3 (es) Ligandos de prote�?nas priones y procedimientos de uso.
Yadavalli et al. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation
Šerbec et al. Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue
Mishra et al. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders
CL2008003089A1 (es) Metodo para tratar enfermedad de alzheimer que comprende un regimen de un anticuerpo que se un epitopo en el n-terminal del peptido amiloide beta, anticuerpo humanizado contra la proteina amiloide beta que tiene sustituidas las posiciones 234, 235, y 237 por alanina en la region constante de las cadenas pesadas.
GT200600182A (es) Anticuerpos dirigidos contra el peptido amiloide beta y metodo que utilizan los mismos
ES2536974T3 (es) Péptidos de epítopos del receptor de EGF y usos de los mismos
CA2231409A1 (en) Antibodies specific for native prpsc
AR062065A1 (es) Anticuerpo humanizado
AR069085A1 (es) Anticuerpos especificos de los peptidos beta- amiloides y sus usos como agentes de diagnostico o drogas
WO2012140296A1 (es) Anticuerpo, kit y metodo para la determinacion de peptidos amiloides
DK1571970T3 (da) Diagnose og monitorering af sygdomme
DE60136054D1 (de) Apoptose-induzierendes polypeptid
WO2003085086A3 (en) Motif-grafted hybrid polypeptides and uses thereof
Choi et al. Uptake and degradation of protease-sensitive and-resistant forms of abnormal human prion protein aggregates by human astrocytes
EA200900373A1 (ru) Реконструированные сурфактанты, обладающие улучшенными свойствами
AR029098A1 (es) Anticuerpos capaces de detectar selectivamente isoformas de prion prpsc
RU2011153023A (ru) Конъюгат амилоидного пептида и композиция на его основе для лечения или предупреждения заболевания, ассоциированного с отложением амилоидных белков
EP1577320B1 (en) Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides
Gao et al. Recombinant neural protein PrP can bind with both recombinant and native apolipoprotein E in vitro
Jäkel et al. Surface-bound myeloperoxidase is a ligand for recognition of late apoptotic neutrophils by human lung surfactant proteins A and D
Xue et al. A non-peptidic MAS1 agonist AVE0991 alleviates hippocampal synaptic degeneration in rats with chronic cerebral hypoperfusion
Spodzieja et al. Interaction of serum amyloid A with human cystatin C—identification of binding sites
Zoega et al. Proteinase 3 carries small unusual carbohydrates and associates with αlpha-defensins

Legal Events

Date Code Title Description
FG Grant, registration